Retour sur lavenir.net
   UMICORE 25.960 € (+15,58 %)     PROXIMUS 6.520 € (+1,64 %)     DEME GROUP 199.400 € (+2,89 %)     SOLVAY 27.140 € (+1,50 %)     EVS BROADC.EQUIPM. 37.450 € (+4,17 %)     SYENSQO 60.050 € (+5,26 %)     KINEPOLIS GROUP 29.550 € (0,00 %)     KBC ANCORA 78.500 € (+1,16 %)     ARGENX SE 687.200 € (-1,58 %)     KBC 112.600 € (+0,81 %)     ACKERMANS V.HAAREN 284.600 € (-0,63 %)     WDP 21.960 € (-0,45 %)     UCB 239.100 € (-0,91 %)     NYXOAH 2.520 € (-6,15 %)     AB INBEV 68.540 € (+0,79 %)     AGEAS 67.600 € (+0,60 %)     GIMV 48.000 € (+1,16 %)     COLRUYT 31.960 € (+0,63 %)     ASCENCIO 49.600 € (-0,70 %)     COFINIMMO 83.050 € (-0,78 %)     VIOHALCO 17.860 € (-0,78 %)     ECONOCOM GROUP 1.470 € (-0,34 %)     IBA 14.720 € (-0,14 %)     BREDERODE 101.200 € (+1,00 %)     ONWARD MEDICAL 2.805 € (+0,72 %)     ACCENTIS 0.027 € (0,00 %)     MONTEA 69.900 € (+0,43 %)     AGFA-GEVAERT 0.469 € (+1,19 %)     ELIA GROUP 134.300 € (-0,37 %)     BARCO 9.000 € (+2,16 %)     BIOTALYS 2.765 € (-0,54 %)     GBL 82.300 € (+0,98 %)     MELEXIS 79.800 € (+4,52 %)     BPOST 1.642 € (-4,42 %)     VAN DE VELDE 30.300 € (-1,30 %)     CENERGY 25.780 € (+2,55 %)     TITAN S.A. 48.220 € (0,00 %)     DECEUNINCK 2.050 € (+0,49 %)     NEXTENSA 46.630 € (+1,37 %)     CARE PROPERTY INV. 12.820 € (-3,03 %)     WERELDHAVE BELGIUM 51.600 € (-1,53 %)     VASTNED 28.500 € (+1,97 %)     TESSENDERLO 21.700 € (+1,88 %)     VGP 80.200 € (+2,17 %)     SOFINA 212.200 € (-0,56 %)     JENSEN-GROUP 66.600 € (-3,20 %)     CMB.TECH 12.860 € (+0,63 %)     CIE BOIS SAUVAGE 321.000 € (+3,55 %)     SIPEF 100.000 € (+0,40 %)     RETAIL ESTATES 67.200 € (-0,59 %)     CELYAD ONCOLOGY 0.291 € (-1,69 %)     BANQUP GROUP 2.520 € (-3,08 %)     MATERIALISE 4.860 € (-0,41 %)     CAMPINE 222.000 € (+1,83 %)     TUBIZE-FIN 201.800 € (-1,37 %)     FAGRON 23.800 € (-0,21 %)     AEDIFICA 70.750 € (-0,77 %)     FLUXYS BELGIUM D 22.200 € (-0,89 %)     XIOR 27.700 € (-0,36 %)     SHURGARD 25.250 € (-0,98 %)  
   SANOFI 72.720 € (-0,87 %)     AMUNDI 84.950 € (+0,59 %)     ARCELORMITTAL SA 54.900 € (+7,10 %)     QUADIENT 11.440 € (-0,17 %)     ING GROEP N.V. 25.425 € (+1,07 %)     VOLTALIA 7.000 € (+0,14 %)     HEINEKEN 64.460 € (-0,46 %)     UBISOFT ENTERTAIN 5.060 € (+1,93 %)     SCHNEIDER ELECTRIC 268.400 € (+1,17 %)     VOPAK 46.240 € (+2,80 %)     MERCIALYS 11.640 € (-0,34 %)     ID LOGISTICS GROUP 352.500 € (+0,57 %)     TRIGANO 158.400 € (+2,00 %)     RUBIS 35.040 € (+0,40 %)     WENDEL 87.650 € (+0,57 %)     STELLANTIS NV 6.484 € (+3,71 %)     NANOBIOTIX 44.100 € (+9,54 %)     ASML HOLDING 1 327.000 € (+4,83 %)     ACCOR 44.030 € (+0,76 %)     SOCIETE GENERALE 66.520 € (-0,39 %)     WOLTERS KLUWER 57.100 € (-6,33 %)     TOTALENERGIES 77.810 € (-0,63 %)     RENAULT 28.100 € (+2,18 %)     BAM GROEP KON 9.220 € (+0,27 %)     CAPGEMINI 96.740 € (-2,48 %)     ABN AMRO BANK N.V. 31.770 € (+8,65 %)     GETLINK SE 18.660 € (+0,65 %)     HERMES INTL 1 582.500 € (+0,22 %)     PHARMING GROUP 1.137 € (+2,43 %)     DSM FIRMENICH AG 66.260 € (+1,94 %)     UMG 19.475 € (-1,29 %)     NEOVACS 0.000 € (0,00 %)     STMICROELECTRONICS 52.340 € (+9,79 %)     AUBAY 51.900 € (+0,39 %)     FNAC DARTY 35.300 € (+0,14 %)     ENGIE 27.400 € (+0,88 %)     ASM INTERNATIONAL 874.400 € (+4,74 %)     AKZO NOBEL 49.450 € (+0,96 %)     LDC 115.400 € (-0,35 %)     TKH GROUP 48.180 € (+4,02 %)     VIRBAC 341.000 € (-1,30 %)     LABO EUROMEDIS 5.300 € (-2,75 %)     SENSORION 0.430 € (-3,48 %)     XILAM ANIMATION 3.680 € (-2,13 %)     PERNOD RICARD 60.700 € (-1,30 %)     BNP PARIBAS ACT.A 91.410 € (+1,11 %)     PROSUS 40.015 € (+4,03 %)     PUBLICIS GROUPE SA 76.440 € (-1,42 %)     INVIBES ADVERTSING 0.860 € (-10,42 %)     ATON 0.015 € (-8,33 %)     HEIJMANS KON 89.900 € (+0,62 %)     MAGNUM 12.650 € (-1,85 %)     GENOWAY 2.400 € (-2,44 %)     SOITEC 155.850 € (+7,71 %)     BOUYGUES 50.900 € (+0,63 %)     RELX 26.960 € (-4,67 %)     EBUSCO HOLDING 0.296 € (+1,02 %)     NOVACYT 0.640 € (-19,70 %)     ORANGE 18.445 € (+0,60 %)     ESSILORLUXOTTICA 170.450 € (+2,74 %)  
AMDOCS LIMITED
DOX - GB0022569080 - US
59,930 USD  15:45
-3,87 %
13/05/2026 22:15

Qué tal Móvil Selects Amdocs connectX to Launch Multi-Aggregator MVNO Platform, Accelerating Time to Market

With Amdocs connectX, Qué tal Móvil's new platform accelerates time to market while enabling seamless integrations, flexible payments, and improved customer access across a growing partner ecosystem

JERSEY CITY, NJ / ACCESS Newswire / May 13, 2026 / Amdocs (NASDAQ:DOX), a leading provider of software and services for communications and media companies, today announced that Qué tal Móvil, a US-based Mobile Virtual Network Operator (MVNO), has successfully launched a new multi-aggregator, multi-payment, and multi-channel activation platform, enabled by the Amdocs connectX platform and delivered in collaboration with PartnerSolve.

The new platform enables Qué tal Móvil to seamlessly integrate with multiple aggregation partners - including MVNO Connect and Helix Wireless - while supporting a wide range of payment methods and sales channels across the full subscriber lifecycle. This includes new activations, number portability, refills, and additional transaction types, all delivered through a scalable and flexible architecture.

By leveraging Amdocs connectX, Qué tal Móvil has been able to simplify operational complexity and accelerate its go-to-market strategy, enabling rapid onboarding of partners and expansion of commercial offerings.

"With Amdocs connectX, we were able to focus on growing our business and executing our marketing strategy, while relying on a robust platform to manage the complexity behind the scenes," said Daniel Barsoum, CEO at Qué tal Móvil. "The speed of deployment and minimal upfront investment allowed us to launch quickly and scale with confidence."

The implementation also incorporates PartnerSolve's integration framework, enabling open and extensible connectivity across multiple ecosystem partners.

"This project represents a significant milestone in building a universal integration layer that connects MVNOs with a broad ecosystem of partners," said Andy Hopkins, Founder of PartnerSolve. "Our goal is to unlock new revenue opportunities and provide MVNOs with the tools they need to scale efficiently and remain competitive."

"Enabling Qué tal Móvil to go to market with a robust, AI‑enabled connectivity offering is a testament to the power of the Amdocs connectX platform," said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. "By leveraging connectX to facilitate agentic activation, Qué tal Móvil is demonstrating real innovation in how MVNOs can scale faster, differentiate their services, and deliver smarter customer experiences in an increasingly competitive market."

Supporting Resources

About Amdocs

Amdocs helps the world's leading communications and media companies deliver exceptional customer experiences through reliable, efficient, and secure operations at scale. We provide software products and services that embed intelligence into how work runs across business, IT, and network domains - delivering measurable outcomes in customer experience, network performance, cloud modernization, and revenue growth. With our talented people, and more than 40 years of experience running mission-critical systems around the globe, Amdocs runs billions of transactions daily. Our technology is relied on every day, connecting people worldwide and advancing a more inclusive, connected world. Together, we help those who shape the future to make it amazing. Amdocs is listed on the NASDAQ Global Select Market (NASDAQ: DOX) and reported revenue of $4.53 billion in fiscal 2025. For more information, visit www.amdocs.com.

About Qué tal Móvil

Qué tal Móvil provides wireless plans and services designed to keep customers connected, with a strong focus on serving diverse communities, including native Spanish-speaking customers. For more information, visit www.quetalmovil.com.

About PartnerSolve

PartnerSolve is a management consulting firm specializing in back-office operations, integration, and control frameworks. The company enables organizations to build scalable, connected ecosystems and optimize end-to-end operations. Learn more at: www.partnersolve.com.

Amdocs' Forward-Looking Statement

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2025, filed on December 15, 2025, and for the first quarter of fiscal 2026 on February 17, 2026.

Media Contacts
Mario Hajiloizi
Amdocs Public Relations
E-mail: mario.hajiloizi@amdocs.com

SOURCE: Amdocs Management Limited



View the original press release on ACCESS Newswire

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière